Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212041
Product Number: 001
Approval Date: Sep 15, 2020
Applicant Holder Full Name: SCIEGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information